Quantum Achievements Win Nobel Prize in Chemistry

John A. Pople Sharing the 1998 Nobel Prize in chemistry are a physicist and a developer of computational codes that made the physicist's concepts more easily applicable to the study of large molecular systems. Walter Kohn, 75, of the University of California at Santa Barbara, and John A. Pople, 72, of Northwestern University, have made pioneering contributions in developing quantum chemistry methods that can be used for theoretical studies of the properties of molecules and the chemical proces

Written byIlene Schneider
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share


John A. Pople
Sharing the 1998 Nobel Prize in chemistry are a physicist and a developer of computational codes that made the physicist's concepts more easily applicable to the study of large molecular systems. Walter Kohn, 75, of the University of California at Santa Barbara, and John A. Pople, 72, of Northwestern University, have made pioneering contributions in developing quantum chemistry methods that can be used for theoretical studies of the properties of molecules and the chemical processes in which they are involved. Kohn was cited for the development of the density-functional theory and Pople for the development of computational methods in quantum chemistry.

Kohn, a physicist, says of winning the chemistry prize: "You may think they made a mistake, but interdisciplinary acts can be fruitful."

Quantum mechanics makes it theoretically possible to understand and calculate how electrons and atomic nuclei interact to build up matter in all its forms. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies